Race against virus: new treatment tested for transplant patients fighting deadly infection
Disease control
Recruiting now
This study aims to determine which of two intravenous antiviral drugs works better to control adenovirus infections in children and adults who have recently received stem cell transplants. The trial will enroll 180 participants who will receive either brincidofovir or cidofovir u…
Phase: PHASE3 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC